norepinephrine-dopamine reuptake inhibitors (NDRIs)
« Back to Glossary IndexNDRIs (norepinephrine-dopamine reuptake inhibitors) are medications that block the reabsorption (reuptake) of specific neurotransmitters (norepinephrine and dopamine) after they have been excreted from a nerve cell. This inhibition of the reabsorption results in more activity of these specific neurotransmitters throughout the brain. NDRIs are commonly used to treat clinical depression, ADHD and narcolepsy. NDRI medications approved for use in the U.S. include methylphenidate (Ritalin), bupropion (Wellbutrin) and solriamfetol (Sunosi).